Good Lifestyle

Your daily drugs are there to help you deal with current health problems. Whether forapproach high cholesterol, Help youhave a good night, or relieve a specific condition, they are supposed to be a way to help improve your quality of life. And thanks to the vigilant eye of your doctor, most patients do not have a second thought to their safety when they go to seek their prescriptions. But now, Food & Drug Administration (FDA) warns that anyone who takes certain common drugs should call its health care provider immediately. Read the rest to see which daily pills could create a major health problem.

Read this then:If you have one of these Colgate toothpaste, get rid of it, the FDA warns.

Like food and drinks, over-the-counter medicines (OTC) and prescription drugs are subject to reminders when security is in question, including some recently. In July, Vi-Jon, LLC, based in Tennessee, announced that it hadexpanded an initial voluntary reminder From its laxative saline solution Citrate magnesium for the third time. The updateAddition of 63 new products, including the versions of grapes, lemon, and cherry of the drugs sold at CVS, Walgreens and Rite Aid Stores Nationwide, as well as in Walmart, Publix, Kroger, Harris Teeter and others. The company claims to have drawn the product after third -party tests have returned positive forLiquefaciens gluconacetobacter bacteria.AE0FCC31AE342FD3A1346EBB1F342FCB

The FDA also announced in JulyFamily dollar had issued a new reminder of 430 toiletries, hygiene products and over -the -counter medicines. Affected products have completed11 pages of a document, including popular name brands such as Dayquil, Colgate, Listerine, Crest, Arm & Hammer, Icy Hot, Suave, Purell, Dial, St. Ives, Secret, Coppertone, Dove, Blisthex, Tylenol, Neutrogena, etc. The company said that the products had been "stored outside of labeled temperature needs" and "inadvertently shipped to certain stores" between May and June.

And on September 26, the health agency alerted the public from another recall, this time from New JerseyEugia US LLC (Formerly Auromedics Pharma LLC) for an ACYCLOVIVE ACYCLOVIVE SODIUM IS LOT 500 mg by 10 ml (50 mg / ml), 10 ml of single dose bottle, also known as Zovirax brand. The company said that customer complaints noting "the presence of dark, brown and black particles inside the bottle" led toReminder of the drug, which is used to treat the herpes virus.

But now, officials warn against another potential health risk linked to popular drugs.

On September 29, the FDA announced thatGolden State Medical Supply, Incorporated (GSMS, Inc.) had issued a voluntary recall for two of his prescription drugs, clopidogrel tablets 75 mg and ATENOLOL 25 mg tablets. The affected products were initially sold in bottles of 1,000 accounts with the expiration date of 12/2023.

The company claims to have initiated the recall "by abundance of prudence" after receiving a report according to which a bottle containing clopidogrel tablets 75 mg was misused in the form of ATENOLOL 25 mg tablets. The agency's opinion specifies that the recall only affects the products with the Lot GS046745 number number and that no other clopidogrel or atenolol sold by GSMS is included.

RELATED:For more up-to-date information, register for our daily newsletter.

According to the FDA, the Atenolol is a prescription drug used to lower blood pressure in the treatment of hypertension. On the other hand, doctors prescribe clopidogrel to patients to reduce the risk of stroke, blood clot or "serious heart problems for patients who have [a] heart attack, serious chest pain or problems of problems traffic "as indicated on the product label.

The agency warns that the labeling mixture could lead patients to take atenolol to suddenly stop their dosage, increasing the risk of heart attack, as well as "hypertensive and arrhythmical undesirable events" due to the rapid removal of the effects medication. The opinion also stresses that prescribed Attenolol patients often take other anticoagulant and antiplatelet drugs that could considerably increase their risk of bleeding if they unconsciously add it to their daily diet.

The FDA reports that the prizes affected were mainly sold to the amercebergen and McKesson wholesalers and that GSMS has since asked to quarantine and stop distributing the products. They also told companies to inform all customers - including pharmacies and consumers - by sending them a copy of the recall notice, as well as a "recall response form, and a letter to consumers, to patients and caregivers ".

Patients with questions are invited to contact their doctor or health care provider. Customers can also reach GSMS by calling the telephone number listed in the FDA advice.